Breadcrumb Navigation:

Home > Research > Research News

Research News

TitleDate
MS Trial Alert: Investigators Nationwide Recruiting People with All Types of MS for Early, Phase I Study to Determine Safety of Experimental AntibodyMay 22, 2013
UPDATED: Clinical Trial Results Announced in Study of Peginterferon Beta-1a - Company Submits Application to FDAMay 21, 2013
Studies Report Progress Understanding What Drives Repair of the Brain’s Insulating Myelin, Which is Damaged by MSMay 08, 2013
Study Finds that the Incidence of MS Appears to be Higher in African American Women Than in Caucasians, Contradicting Previous FindingsMay 06, 2013
Positive Results Announced for Aubagio in Phase III Study of People at High Risk for MSApr 26, 2013
Results Published from Phase II Trial of Daclizumab in Relapsing MSApr 25, 2013
Cases of PML Reported in People Taking Fumarate-based Treatments for Psoriasis - No cases reported in People with MS Taking Related Product, TecfideraApr 24, 2013
MS Trial Alert: Drug Study at NIH Recruiting People with Primary-Progressive MSApr 22, 2013
Meeting of MS Outcome Assessments Consortium and FDA Clears Pathway for New Tool for Clinical Trials in MS, Particularly Progressive FormsApr 18, 2013
$18 Million in New Research Projects Launched To Stop MS, Restore Function and End It Forever - Part of 2013 investment of over $47 million in cutting-edge research projectsApr 18, 2013
MS Trial Alert: Drug Study at NIH Recruiting People with Secondary-Progressive MSApr 15, 2013
Month of Birth May Influence Risk of MS by Promoting Changes in Immune System DevelopmentApr 15, 2013
National MS Society Partners with the University of Miami and Accera, Inc. to Test Novel “Medical Food” for MS Cognitive ImpairmentApr 11, 2013
New Study Reports That an Online Community of People with MS May Be Used to Study the DiseaseApr 11, 2013
Emerging Therapies, Risk Factors and Other MS Research News from American Academy of Neurology MeetingApr 10, 2013
Canbex Therapeutics Raises $ 3.2 million to Develop Treatment for Debilitating Muscle Spasms Associated with MSApr 09, 2013
FDA Approves Twice a Day Capsules Called Tecfidera™ (formerly called BG-12) for Relapsing MSMar 27, 2013
Oxford’s Professor George Ebers Wins 2013 John Dystel Prize for MS Research: Revolutionized our understanding of MS Mar 21, 2013
Dr. Stephen Hauser, National MS Society Leadership Volunteer, Wins Charcot AwardMar 15, 2013
National MS Society-Supported Studies Point to Possibility That Dietary Salt May Stimulate Activity of Key Immune Cells Involved in MS AttacksMar 06, 2013

Back to top